Mahlon Raymund, PhD

Articles by Mahlon Raymund, PhD

Cost-Effectiveness of Pneumococcal Polysaccharide Vaccine Among Healthcare Workers During an Influenza Pandemic

ByKenneth J. Smith, MD, MS,Mahlon Raymund, PhD,Mary Patricia Nowalk, PhD, RD,Mark S. Roberts, MD, MPP,Richard K. Zimmerman, MD, MPH

March 9th 2010

Pneumococcal polysaccharide vaccination of healthcare workers during an influenza pandemic is cost-effective from a societal perspective but not from a hospital perspective without external subsidy.

Office Manager and Nurse Perspectives on Facilitators of Adult Immunization

ByMary Patricia Nowalk, PhD, RD,Melissa Tabbarah, PhD, MPH,Jonathan A. Hart, MS,Dwight E. Fox, DMD,Mahlon Raymund, PhD,Stephen A. Wilson, MD, MPH,Richard K. Zimmerman, MD, MPH,for the FM-PittNet Practice Based Research Network

October 8th 2009

Factors significantly associated with adult vaccination rates in primary care practices were patients’ age, race, scheduled well-visit length, and nurses’ vaccination status.

Relationship between Primary Payer and Use of Proactive Immunization Practices: A National Survey

ByRichard K. Zimmerman, MD, MPH,Tammy A. Mieczkowski, PhD,Mahlon Raymund, PhD

May 1st 1999

Mahlon Raymund, PhD

Articles by Mahlon Raymund, PhD

Cost-Effectiveness of Pneumococcal Polysaccharide Vaccine Among Healthcare Workers During an Influenza Pandemic

Office Manager and Nurse Perspectives on Facilitators of Adult Immunization

Relationship between Primary Payer and Use of Proactive Immunization Practices: A National Survey

Latest Updated Articles

Trending on AJMC

5 FAQs: Ebola Outbreaks and the Challenge of Public Trust

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Incretin Innovation, Metabolic Liver Disease, and Cardiovascular Risk Reduction Dominate ADA 2026

Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD

Real-World Resmetirom Gains in MASH: Naim Alkhouri, MD